Doxazosin Tablet
Product Images NDC 60505-0095

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 60505-0095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin-1mg-100.jpg (Doxazosin 1mg 100)

Doxazosin tablets are available in 1mg strength and are manufactured by Apotex Corp. The tablets are USP approved and should only be taken under the supervision of a Pharmacist or Doctor. The bottle contains 100 tablets and the product code is 5050500930.*

FDA Label Image

Doxazosin-2mg-100.jpg (Doxazosin 2mg 100)

Doxazosin is a medication available in tablet form with a strength of 2mg. It is manufactured by Apotex Corp. The text also includes a lot number, dosage information, and the name of the medication.*

FDA Label Image

Doxazosin-4mg-100.jpg (Doxazosin 4mg 100)

FDA Label Image

Doxazosin-8mg-100.jpg (Doxazosin 8mg 100)

FDA Label Image

Doxazosin-structure.jpg (Doxazosin Structure)

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Table3.jpg (Table3)

The text provides a summary of effectiveness data in placebo-controlled trials for doxazosin in the treatment of benign prostatic hyperplasia. The study reports maximum flow rate and symptom score changes in patients who received either doxazosin or a placebo. The efficacy of doxazosin was evaluated in three separate studies where baseline data and changes in symptoms were reported. The text also includes the duration of the trials, the titration used, and the dose of the drugs administered.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.